Bertrand de Lavenne

Alexander Hughes is an international Executive Search firm advising senior management on key talent acquisition supporting their firm’s success: Executive and non-executive Directors, senior managers and recognized experts.

Time for pragmatic understanding of the changes required both today and tomorrow to the internal organization and customer management: - Innovate business models beyond volume - Pioneer new integrated models of care delivery - Design patient & customer experiences that matter - Hardwire patient & customer centricity into their operating models - Prove the value they create internally and externally

Executive Search - Recruiting - Interim Management

USD 1.7 B • Management: 1’500 people #1 Worldwide Affiliate after the U.S.A. in Mylan French Market leadership: #2 in units, #3 in volume, #1 in Generic, #1 in OTC INN, #1 in Flu Vaccine • Full P&L Responsibility of Mylan France Operations including a portfolio of Branded Products, Generics, OTC, Medical Devices and Flu Vaccine

USD 1.1 B • Management: 300 people #1 Retail Division after the U.S.A. in Mylan French Market leadership: #1 in Generic, #1 in OTC INN, #1 in Flu Vaccine • Full P&L responsibility of the Retail Division incl. Generics, OTC, Medical Devices and Flu Vaccine

USD 165M • 100 people • Full P&L Responsibility: lead the local operations with a particular focus on Oncology and Hepatitis

USD 80M • 60 people • Full P&L Responsibility: lead the transformation of the UK and Irish affiliates adapting to a changing and challenging environment internally and externally (business model turnaround, new business development: telehealth and digital technologies)

USD 1.9B • 10 people • Lead global marketing brands in Antibiotics, Pain, CNS & Vaccines markets: Klacid, Brufen, Influvac by reviewing and challenging affiliates marketing and business plans

Expert Advisory Network • Independent Consultancy • Serve various Pharmaceutical companies launching new brands or new business in China/Asia around Reorganisation – Transformation – Doing business in China or Asia

USD 430M • 100 people • Function as key member of the Novartis Pharma China Executive Committee, managed the General Medicine Portfolio by directing a 100-members marketing team and further support its growing USD 430M business

USD 2B • Lead strategic implementation and execution of marketing activities and guided Direct Countries (China, Turkey, Russia and India) as well as Regional Offices (APAC and Eastern Europe Middle East Africa)

USD 58M • 23 people • Full P&L accountability with USD 58M in sales and management of 23 employees